Falcon (FALCONTECH)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 10.69% indicates the business is still expanding at the top line.
• P/E of 11.00 is modest on trailing earnings, offering cheapness if earnings stabilise.
• ROCE of 10.59% suggests operational capital returns are positive despite weak bottom line.
• Promoter holding of 42.98% gives promoters meaningful skin in the game.

Concerns

• Profit growth collapsed by 52.44% and latest quarter net profit is ₹0 Cr, showing severe margin pressure.
• Piotroski F-score of 4/9 signals weak overall financial health.
• Critical balance sheet inputs—book value, ROE, debt/equity—are unavailable, limiting any margin-of-safety calculation.
• No dividend and a ₹8 Cr market cap make it a highly illiquid, speculative microcap.

AI Analysis

I begin with a simple confession: the more data missing, the less interested I am. Falcon shows a name and a price, but for a value investor, that is not enough. At ₹14.10, the market capitalises the company at just ₹8 crore. A P/E of 11 looks inexpensive, but that is trailing optics; profits have fallen 52.44% while sales grew only 10.69%. In the latest quarter, sales were ₹14 crore and net profit was ₹0 crore. A business earning zero in its most recent quarter is not a compounding machine; it is a question mark. What do I like? Sales are still growing, and ROCE is 10.59%, which means existing capital is not being destroyed yet. Promoter holding of 42.98% is reasonable and aligns owners with minority shareholders. But that is where comfort ends. I cannot assess financial health because book value, ROE, and debt-equity are all unavailable. The Piotroski F-score of 4 out of 9 reinforces my caution—this is a weak fundamental score, not a sign of hidden quality. There is no dividend, so I am not being paid to wait. The PEG ratio of 1.03 is dangerous in this context; it uses a growth rate that the latest profit collapse contradicts. This is not a stalwart or a fast grower. It is a possible turnaround, but only after margins prove they can recover. Until I see consistent quarterly profits, honest disclosure of the balance sheet, and evidence that the 52% earnings deterioration is behind the company, I will keep Falcon in the 'too hard' pile. In Graham's world, a low price is not a margin of safety unless the underlying business is undeniable. Here, it is not.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer